Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-100217
Filing Date
2024-08-23
Accepted
2024-08-23 16:34:07
Documents
68
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pkbo-20240630.htm   iXBRL 10-Q 1859290
2 EX-31.1 pkbo-ex31_1.htm EX-31.1 16420
3 EX-31.2 pkbo-ex31_2.htm EX-31.2 16397
4 EX-32.1 pkbo-ex32_1.htm EX-32.1 7388
5 EX-32.2 pkbo-ex32_2.htm EX-32.2 7373
  Complete submission text file 0000950170-24-100217.txt   8772940

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pkbo-20240630.xsd EX-101.SCH 1348718
71 EXTRACTED XBRL INSTANCE DOCUMENT pkbo-20240630_htm.xml XML 1523211
Mailing Address 4900 HOPYARD ROAD, SUITE 100 PLEASANTON CA 94588
Business Address 4900 HOPYARD ROAD, SUITE 100 PLEASANTON CA 94588 (925) 463-4800
Peak Bio, Inc. (Filer) CIK: 0001834645 (see all company filings)

EIN.: 852448157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39951 | Film No.: 241236754
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)